Laith N Al-Eitan1,2, Doaa M Rababa'h3, Mansour A Alghamdi4,5. 1. Department of Applied Biological Sciences, Jordan University of Science and Technology, Irbid, 22110, Jordan. lneitan@just.edu.jo. 2. Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, 22110, Jordan. lneitan@just.edu.jo. 3. Department of Applied Biological Sciences, Jordan University of Science and Technology, Irbid, 22110, Jordan. 4. Department of Anatomy, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia. 5. Genomics and Personalized Medicine Unit, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.
Abstract
BACKGROUND: Like other complex diseases including drug addiction, genetic factors can interfere with the disease. In this study, three opioid genes (OPRM1, OPRD1, and OPRK1) were examined for an association with drug addiction among Jordanian males. METHODS: The study involved 498 addicts, in addition to 496 healthy controls and all from Arab descent. RESULTS: The findings in this study showed that rs1799971 of the OPRM1 gene was in association with drug addiction for both alleles and genotypes with P-values = 0.002 and 0.01, respectively. In addition, a significant association between the dominant model (A/A vs G/A-G/G) of rs1799971 (OPRM1) and drug addiction (P-value = 0.003, OR = 1.59 (1.17-2.15)) was detected. Moreover, a genetic haplotype (AGGGCGACCCC) of theOPRM1 gene revealed a significant association with drug addiction (P-value = 0.01, OR = 1.56 (1.15-2.12)). We also found that the age of addicts, smoking, and marital status with genetic variants within OPRM1, OPRD1, and OPRK1 genes may be implicated in drug addiction risk. CONCLUSION: We propose that rs1799971 of the OPRM1gene is a genetic risk factor for drug addiction among Jordanian males.
BACKGROUND: Like other complex diseases including drug addiction, genetic factors can interfere with the disease. In this study, three opioid genes (OPRM1, OPRD1, and OPRK1) were examined for an association with drug addiction among Jordanian males. METHODS: The study involved 498 addicts, in addition to 496 healthy controls and all from Arab descent. RESULTS: The findings in this study showed that rs1799971 of the OPRM1 gene was in association with drug addiction for both alleles and genotypes with P-values = 0.002 and 0.01, respectively. In addition, a significant association between the dominant model (A/A vs G/A-G/G) of rs1799971 (OPRM1) and drug addiction (P-value = 0.003, OR = 1.59 (1.17-2.15)) was detected. Moreover, a genetic haplotype (AGGGCGACCCC) of theOPRM1 gene revealed a significant association with drug addiction (P-value = 0.01, OR = 1.56 (1.15-2.12)). We also found that the age of addicts, smoking, and marital status with genetic variants within OPRM1, OPRD1, and OPRK1 genes may be implicated in drug addiction risk. CONCLUSION: We propose that rs1799971 of the OPRM1gene is a genetic risk factor for drug addiction among Jordanian males.
Entities:
Keywords:
Drug addiction; Jordan; Opioids; Polymorphism
Authors: James J Crowley; David W Oslin; Ashwin A Patkar; Edward Gottheil; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini; Dorothy E Grice Journal: Psychiatr Genet Date: 2003-09 Impact factor: 2.458
Authors: Bruno Georg Oertel; Mattias Kettner; Klaus Scholich; Christoph Renné; Bianca Roskam; Gerd Geisslinger; Peter Harald Schmidt; Jörn Lötsch Journal: J Biol Chem Date: 2008-12-30 Impact factor: 5.157
Authors: R C Crist; L M Ambrose-Lanci; M Vaswani; T K Clarke; A Zeng; C Yuan; T N Ferraro; H Hakonarson; K M Kampman; C A Dackis; H M Pettinati; C P O'Brien; D W Oslin; G A Doyle; F W Lohoff; W H Berrettini Journal: Drug Alcohol Depend Date: 2012-07-12 Impact factor: 4.492